FDA Encourages Inclusion of Older Adult Patients in Cancer Clinical Trials

From the U.S. Food & Drug Administration

Enrolling a broad representation of patients in clinical trials is an important tenet of clinical research as it facilitates a better understanding of the drug’s benefits and risks across the patient population likely to take the drug. However, because cancer incidence increases with age, and given the aging U.S. population, it’s particularly important now more than ever to ensure that older adults are also enrolling in cancer clinical trials…



Forgotten Password?